
|Articles|December 1, 2002
Supplements and Featured Publications
- Health-Related Consequences of and Treatment Strategies for Overactive Bladder
- Volume 8
- Issue 19 Suppl
Long-term Health-Related Quality of Life of Patients Receiving Extended-Release Tolterodine for Overactive Bladder
Advertisement
Articles in this issue
about 23 years ago
Participating Facultyabout 23 years ago
Health-Related Consequences of Overactive BladderNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Trump Strikes 9 New Pricing Agreements as Drugmakers Navigate Tariff, Regulatory Pressure
2
Fuzuloparib Monotherapy Improves PFS in Advanced Ovarian Cancer, but Adding Apatinib Offers No Additional Benefit
3
FDA Approves Aficamten for Obstructive Hypertrophic Cardiomyopathy
4
Top 5 Myasthenia Gravis Content of 2025
5







































